The MD Anderson group initially described results with Hyper-CVAD/MA, [28] a more intensive regimen that includes hyperfractionated cyclophosphamide and alternating high-dose methotrexate–cytarabine ...
Pediatric-inspired protocols and hyper-CVAD conferred comparable survival for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia, according to study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback